Propofol slow administration for Low Blood Pressure

Phase 3

Recruiting

Led By Tanaya Sparkle

Research Sponsored by University of Toledo

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediate post-op to 30 days post operatively

Awards & highlights

Study Summary

This trial is testing whether giving propofol more slowly causes fewer problems with blood pressure than the standard way it's given.

Eligible Conditions

Low Blood Pressure

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediate post-op to 30 days post operatively

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediate post-op to 30 days post operatively

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediate post-op to 30 days post operatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patients administered Propofol at a slower rate of infusion will have lower incidence of post induction hypotension than patients administered Propofol at FDA approved rate.

Secondary outcome measures

Patients administered Propofol at a slower rate will have less complications during the early post-op period than patients administered Propofol at FDA approved rate.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Group B- propofol given over 120 secondsExperimental Treatment1 Intervention

Group II: Group A- propofol given at FDA approved administration speedActive Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of ToledoLead Sponsor

7 Previous Clinical Trials

642 Total Patients Enrolled

Tanaya SparklePrincipal InvestigatorUniversity of Toledo

Nitin GoyalPrincipal InvestigatorUniversity of Toledo

~36 spots leftby May 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.